Lamicare Health Group

Lamicare Health Group develops patented, clinically proven dermatology products for global distribution. Our proprietary CEM-K™ active ingredient is derived from sea kelp and backed by independent EU clinical trials showing up to 93% reduction in skin inflammation. We partner with distributors, investors, and licensing partners across Europe, Africa, SE Asia, and the Middle East.